Aspex Management (HK)’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62K Hold
86,666
﹤0.01% 27
2025
Q4
$188K Hold
86,666
﹤0.01% 22
2025
Q3
$478K Hold
86,666
0.01% 24
2025
Q2
$650K Hold
86,666
0.01% 25
2025
Q1
$569K Hold
86,666
0.01% 28
2024
Q4
$1.14M Hold
86,666
0.03% 30
2024
Q3
$492K Hold
86,666
0.01% 28
2024
Q2
$509K Sell
86,666
-1
-0% -$9 0.01% 35
2024
Q1
$784K Hold
86,667
0.02% 32
2023
Q4
$953K Hold
86,667
0.03% 33
2023
Q3
$1.54M Hold
86,667
0.05% 28
2023
Q2
$4.76M Hold
86,667
0.14% 25
2023
Q1
$5.9M Hold
86,667
0.15% 30
2022
Q4
$5.25M Hold
86,667
0.15% 28
2022
Q3
$8.71M Hold
86,667
0.26% 27
2022
Q2
$7.64M Hold
86,667
0.19% 27
2022
Q1
$13.2M Hold
86,667
0.52% 20
2021
Q4
$27.6M Hold
86,667
0.84% 21
2021
Q3
$38.9M Buy
+86,667
New +$27.4M 1.3% 19

Other funds holding RBOT

Aspex Management (HK)'s RBOT Position: Q1 2026 in Review

Aspex Management (HK) held its Vicarious Surgical (RBOT) position steady in Q1 2026 at 86,666 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #27.

Aspex Management (HK) first reported a position in RBOT in Q3 2021 and has held it in 19 quarters since. The position peaked at $38.9M in Q3 2021. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Aspex Management (HK) held 86,666 shares of Vicarious Surgical worth $62K as of Q1 2026.
  • Aspex Management (HK) left its Vicarious Surgical share count unchanged in Q1 2026.
  • Vicarious Surgical made up ﹤0.01% of Aspex Management (HK)'s portfolio in Q1 2026, its #27 holding.
  • Aspex Management (HK) first reported a position in Vicarious Surgical in Q3 2021 and has held it in 19 quarters since.
  • Aspex Management (HK)'s Vicarious Surgical position peaked at $38.9M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Aspex Management (HK)'s 13F filing for Q1 2026, filed 15 May 2026.